Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

AdaptHealth (AHCO) Invested Capital (2018 - 2025)

AdaptHealth has reported Invested Capital over the past 8 years, most recently at $1.6 billion for Q4 2025.

  • Quarterly results put Invested Capital at $1.6 billion for Q4 2025, down 55.7% from a year ago — trailing twelve months through Dec 2025 was $1.6 billion (down 55.7% YoY), and the annual figure for FY2025 was $1.6 billion, down 55.7%.
  • Invested Capital for Q4 2025 was $1.6 billion at AdaptHealth, down from $1.7 billion in the prior quarter.
  • Over the last five years, Invested Capital for AHCO hit a ceiling of $4.4 billion in Q2 2023 and a floor of $1.6 billion in Q4 2025.
  • Median Invested Capital over the past 5 years was $2.2 billion (2022), compared with a mean of $2.8 billion.
  • Biggest five-year swings in Invested Capital: surged 2117.38% in 2021 and later crashed 55.7% in 2025.
  • AdaptHealth's Invested Capital stood at $4.3 billion in 2021, then crashed by 49.33% to $2.2 billion in 2022, then skyrocketed by 67.04% to $3.6 billion in 2023, then decreased by 1.53% to $3.6 billion in 2024, then tumbled by 55.7% to $1.6 billion in 2025.
  • The last three reported values for Invested Capital were $1.6 billion (Q4 2025), $1.7 billion (Q3 2025), and $1.6 billion (Q2 2025) per Business Quant data.